Guidance Ethics Workshop Report: Gene therapy for Sickle Cell Disease

This report describes the proceedings of a Guidance Ethics Workshop undertaken on August 24, 2026. This workshop explored the ethical considerations around the introduction of gene therapies for sickle cell disease, with the goal of identifying the values at stake and options for action that would be uphold or support these values.